BioMarin

YTD

ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO

Alexander Hardy

CEOAlexander Hardy

Employees

3,040

Employees3,040

Headquarters

San Rafael, California

HeadquartersSan Rafael, California

Founded

1997

Founded1997

Employees

3,040

Employees3,040

BMRN Key Statistics

Market cap

11.12B

Market cap11.12B

Price-Earnings ratio

21.52

Price-Earnings ratio21.52

Dividend yield

—

Dividend yield—

Average volume

2.19M

Average volume2.19M

High today

$59.37

High today$59.37

Low today

$57.22

Low today$57.22

Open price

$57.31

Open price$57.31

Volume

2.14M

Volume2.14M

52 Week high

$94.85

52 Week high$94.85

52 Week low

$52.93

52 Week low$52.93

BMRN News

TipRanks 6d

BioMarin’s BMN 349 Study: A New Frontier in Genetic Mutation Treatment

Biomarin Pharmaceutical Inc. ((BMRN)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Prem...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

19.4%

Sell

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.